Objective
The goal of this proposal is to use oculopharyngeal muscular dystrophy (OPMD) as a paradigm to investigate new phannaco-therapeutic approaches based on genorne- and proteome-wide surveys of nonnal and dystrophic muscle. We will screen for genes/proteins capable of suppressing the dystrophic muscle phenotype. Selected candidates will represent the basis for developing a human gene therapy program. To reach this goal, we will generate cellular and animal models amenable to genetic screens and manipulations, and will construct DNA and protein microarrays to compare gene expression profiles in normal and dystrophic muscle. If a particular protein is found under-expressed in disease muscle we will isolate the corresponding cDNA and induce its over-expression in OPMD transgenic mouse model. Additional candidates for human gene therapy are expected to be identified by a genetic screen based on modification of the phenotype in the OPMD Drosophila model.
Fields of science
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
1649-028 Lisboa
Portugal
See on map
Participants (5)
34396 Montpellier
See on map
2333 al Leiden
See on map
06120 Halle (Saale)
See on map
3133 AT Vlaardingen
See on map
3584 CH Utrecht
See on map